Eleusis Health Solutions Ltd
Research and experimental development on biotechnology · Calne
ActiveUnited KingdomIncorporated 2016Private Limited Company
Financial position
Accounts to 2024-12-31 · GBP · Company accounts
Net assets
−£1,390,469
Cash
£0
Turnover
—
Profit / loss
—
Current assets
£262,519
Creditors < 1 year
—
Equity
−£1,390,469
Average employees
2
Balance-sheet trend
GBP · companyFinancial statements
Selected figures from the best-ranked available filing for each period. Missing values remain unknown.
| Reported figures | 2024-12-3112 months · Company | 2023-12-3112 months · Company | 2022-12-3112 months | 2020-12-3112 months | 2019-12-3112 months | 2018-12-3112 months | 2017-12-31 |
|---|---|---|---|---|---|---|---|
| Balance sheet | |||||||
| Net assets | −£1,390,469 | −£1,390,734 | — | — | — | — | — |
| Equity | −£1,390,469 | −£1,390,734 | −£1,370,848 | −£895,448 | −£658,179 | −£477,353 | −£212,423 |
| Assets | |||||||
| Current assets | £262,519 | £265,126 | £267,085 | £353,524 | £89,146 | £33,469 | £200,724 |
| Cash at bank | £0 | £14,586 | £6,268 | £163,832 | £46,380 | £2,935 | £197,768 |
| Debtors | £262,519 | £250,540 | £260,817 | £189,692 | £42,766 | £30,534 | £2,956 |
| Liabilities | |||||||
| Net current assets | −£1,390,469 | −£1,390,734 | −£1,370,848 | −£895,448 | −£658,179 | −£477,353 | −£212,423 |
| Assets less current liabilities | −£1,390,469 | −£1,390,734 | −£1,370,848 | −£895,448 | −£658,179 | −£477,353 | −£212,423 |
| People & pay | |||||||
| Average employees | 2 | 3 | 3 | 1 | 1 | 1 | — |
| Source evidence | View filing | View filing | View filing | View filing | View filing | View filing | View filing |
Secured borrowing
Registered charges, lenders and security interests.
Charges and related records
0 outstanding chargesShow 1 satisfied / released
All Assets · created 2022-07-27 · satisfied 2026-06-11
—
Satisfied